yahoo_financeOriginal article
iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
Data ReadoutpositiveIBIO-610Positive
AI Analysis
Summary
iBio reported that a single dose of IBIO-610 achieved near-complete active Activin E inhibition sustained for eight weeks in an obese non-human primate study, demonstrating potential for obesity treatment.
Clinical Trial Data
Phase
preclinical
Primary Endpoint
Met
Outcome Details
Single dose achieved near-complete active Activin E inhibition through eight weeks in obese non-human primate study
Importance:5/10
Sentiment:
0.70
preclinical_dataobesityActivin_E_inhibitionnon-human_primate_study
Related Companies
Read the original article
Published by yahoo_finance on July 1, 2026 11:00 AM